Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2022-01-13

Clinical Trial Update: Effectiveness of Minocycline-Containing Bismuth Quadruple Therapy for Helicobacter Pylori Eradication [Phase 4]

View source ↗

Summary

Phase 4 trial evaluating effectiveness of a minocycline-containing bismuth quadruple therapy for Helicobacter pylori eradication.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • minocycline-containing bismuth quadruple therapy (minocycline-containing bismuth quadruple therapy)

Snippet

Sponsor: Second Affiliated Hospital, School of Medicine, Zhejiang University | Conditions: Helicobacter Pylori Eradication | Phase 4 | Status: UNKNOWN